‘Potentially Concerning’ Signal in Long-Term Follow-up Data Involving Paclitaxel-Coated Products
Paclitaxel-coated devices were associated with an approximately 50% increased risk of death when compared with control devices.
Vascular Medicine
PREVENTION
Featured Article
Latest News
Increased ABI May Identify Patients With T1D at Risk for CV Autonomic Dysfunction
High ankle-brachial index, a marker of arterial stiffness, may be used to assess the risk for cardiovascular autonomic neuropathy in type 1 diabetes.
Managing Venous Thromboembolism in Transgender Women Receiving Hormone Therapy
Transgender women receiving hormone replacement therapy may be at an increased risk for thromboembolism, though data and recommendations vary across studies.
2011 to 2015 Saw Drop in Delayed Discharge Rates After TAVR
From 2011 to 2015, there was a decline in the rates of delayed discharge following transcatheter aortic valve replacement.
Transcarotid TAVR With Edwards Sapien 3 Effectively Treats Elderly Patients with Severe AS
The clinical outcomes of patients undergoing transcarotid transcatheter aortic valve replacement with the Edwards Sapien 3 device were examined.
Metabolic Modulators May Have Limited Use in Nonobstructive Hypertrophic Cardiomyopathy
Trimetazidine therapy did not improve exercise capacity in symptomatic nonobstructive cardiomyopathy.
Is It Time for Endocrinologists to Join the Vascular Care Team?
As the link between diabetes and PAD becomes more evident, clinicians can best serve patients with these comorbidities by working collaboratively to prevent serious complications.
Long-Term Outcomes May Still Favor Carotid Endarterectomy in Carotid Stenosis
A pooled analysis of patient data analyzed the safety and efficacy of stenting and endarterectomy for symptomatic carotid stenosis.
Rivaroxaban Does Not Reduce VTE Incidence in High-Risk Patients With Cancer
The incidence of venous thromboembolism or death due to venous thromboembolism during 180 days is not significantly reduced for rivaroxaban compared with placebo.
Readmission Risks for Injection Drug Use-Related Infective Endocarditis
Patients with injection drug use-related endocarditis are more likely to be readmitted with endocarditis, septicemia, and drug abuse.
Functional Decline Seen for Many Frail Patients After TAVR, SAVR
Older patients with severe frailty undergoing TAVR and SAVR frequently experience subsequent functional decline or lack of improvement.
Want to read more?
Please login or register first to view this content.
Next post in Vascular Medicine
